Wednesday, 31 May 2023
Trending

Investing

Argus maintains AstraZeneca ADR at 'buy' with a price target of $80.00

Citi Reiterates Sell Rating on ICICI Securities



Argus maintains AstraZeneca ADR at 'buy' with a price target of $80.00

Click Here to Read the Full Original Article at All News…